Imaging MAO-A levels by PET using the deuterium isotope effect

Journal of Nuclear Medicine

Volumn 46, Issue 9, 2005, Pages 1411-1413

  Baldwin, Ronald M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CLORGYLINE; DEUTERIUM; MONOAMINE OXIDASE INHIBITOR; SEROTONIN; TRACER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

DRUG EFFECT; HALF LIFE TIME; HUMAN; IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; ANTIBODY SPECIFICITY; LUNG; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; NOTE; SCINTISCANNING; SMOKING; TISSUE DISTRIBUTION;

DEUTERIUM; HUMANS; LUNG; METABOLIC CLEARANCE RATE; MONOAMINE OXIDASE; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SMOKING; TISSUE DISTRIBUTION;

EID: 27744443467     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Wagner HN Jr. Quantitative imaging of neuroreceptors in the living human brain. Semin Nucl Med. 1986;16:51-62.
2. Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA. 2000;97:9226-9233.
3. Lamelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metabol. 2000; 20:423-451.
4. Fowler JS, Logan J, Wang G-J, et al. Comparison of monoamine oxidase A in peripheral organs in nonsmokers and smokers. J Nucl Med. 2005;46: 1414-1420.
5. Kopin IJ. Monoamine oxidase and catecholamine metabolism. J Neural Transm Suppl. 1994;41:57-67.
6. Johnston JP. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol. 1968;17:1285-1297.
7. Shih JC, Chen K, Ridd MJ. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci. 1999; 22:197-217.
8. Olsson B, Olsson J, Pettersson G. Kinetic isotope effects on the catalytic activity of pig-plasma benzylamine oxidase. Eur J Biochem. 1976;64:327-331.
9. Vetulani J, Nalepa I. Antidepressants: past, present and future. Eur J Pharmacol. 2000;405:351-363.
10. Mizuno Y, Mori H, Kondo T. Potential of neuroprotective therapy in Parkinsons disease. CNS Drugs. 1994;1:45-56.
11. Knoll J. The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal view. Pharmacol Toxicol. 1992;70:317-321.
12. Caldecott-Hazard S, Schneider LS. Clinical and biochemical aspects of depressive disorders. III. Treatment and controversies. Synapse. 1992;10: 141-168.
13. Anderson MC, Hasan F, McCrodden JM, Tipton KF. Monoamine oxidase inhibitors and the cheese effect. Neurochem Res. 1993;18:1145-1149.
14. Dudley GB, Danishefsky SJ, Sukenick G. On the use of deuterium isotope effects in chemical synthesis. Tetrahedron Lett. 2002;43:5605-5606.
15. Yu PH. Three types of stereospecificity and the kinetic deuterium isotope effect in the oxidative deamination of dopamine as catalyzed by different amine oxidases. Biochem Cell Biol. 1988;66:853-861.
16. 11C] clorgyline binding in brain. Nucl Med Biol. 2001;28:779-785.
17. Fowler JS, Wang GJ, Logan J, et al. Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11 L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping. J Nucl Med. 1995;36:1255-1262.
18. Ichise M, Meyer JH, Yonekura Y. An introduction to PET and SPECT neuroreceptor quantification models. J Nucl Med. 2001;42:755-763.
19. 11C]L-deprenylin brain and peripheral organs in humans. Nucl Med Biol. 2004;31:313-319.
20. Logan J, Fowler JS. Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers. Nucl Med Biol. 2005;32:521-529.
21. 11C]L-deprenyl in living baboon brain. J Neurochem. 1988;51:1524-1534.
22. Fowler JS, Logan J, Wang G-J, et al. PET imaging of monoamine oxidase B in peripheral organs in humans. J Nucl Med. 2002;43:1331-1338.
23. Fowler JS, Logan J, Wang G-J, et al. Monoamine oxidase A imaging in peripheral organs in healthy human subjects. Synapse. 2003;49:178-187.